Aug 4, 2021
On this episode, we are joined by MUSC forth year PharmD student, Matthew Brock. We review a patient case that covers multiple co-morbidities. We start by discussing the patient's COPD management and the recommendations from the 2021 GOLD guidelines. We then review low dose rivaroxaban with lose dose aspirin in patients with PAD. Then, we talk about strategies for managing his angina and hypertension considering his past history of ischemic stroke. We close by briefly covering his diabetes and need for smoking cessation.
If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable Power Point slides for each lecture. You can find our account at the website below:
If you have any questions for Cole or me, reach out to us on any of the following:
Text - 415-943-6116
Mike - firstname.lastname@example.org
Cole - email@example.com
Instagram and other social media platforms - @corconsultrx
This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.